Read more at Congressional Lawmakers Relaunch Psychedelics Caucus To Promote Studies On Therapeutic Use March 02, 2023 REPS. CORREA, BERGMAN RE-LAUNCH BIPARTISAN CAUCUS TO EXPLORE PSYCHEDELIC RESEARCH FOR MENTAL HEALTH WASHINGTON, D.C. – Today, Representatives Lou Correa (CA-46) and Jack Bergman (MI-01) announced the re-launch of their Congressional Psychedelics Advancing Therapies (PATH) Caucus for the 118th Congress. Mental health continues to be a relentless challenge for Americans who serve, or have served, in our nation’s armed forces. According to the National Institute of Mental Health (NIMH), approximately 50 million Americans have any mental illness (AMI) at any given time, of which 13 million Americans have serious mental illness (SMI). Johns Hopkins University and New York University are advancing FDA-approved clinical trials using psychedelics to treat addictions and other mental disorders. Therefore, this caucus is not for advancement of psychedelics for other uses, including legalization for recreational use or decriminalization of the compounds.
Marijuana Moment reports
A bipartisan pair of federal lawmakers are rebranding and relaunching a congressional caucus to promote research into and awareness around psychedelic-assisted therapy, hoping to shine a light on the practice’s potential to treat a variety of mental health conditions.
The renamed Congressional Psychedelics Advancing Therapies (PATH) Caucus, which was described exclusively to Marijuana Moment ahead of its formal announcement in a press release on Thursday morning, aims to inform fellow lawmakers of the growing evidence from leading research institutions that therapy involving substances...
Read the full article @ Cannabis Law Report